Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Kyle M Jandrasitz

Kyle M Jandrasitz

Microfluidics International Corporation, USA

Title: Microfluidizer® high-shear technology for manufacturing pharmaceutical drug delivery nanoparticles: From development to production

Biography

Biography: Kyle M Jandrasitz

Abstract

Nanotechnology has revolutionized the pharmaceutical industry, especially with the applications of using nanoparticles (NPs) as drug delivery systems (DDS). These NPs show a number of advantages comparing to conventional methods such as increased bioavailability through enhanced solubility, forming theranostic platforms by co-delivering diagnostic and therapeutic agents, overcome various transport barriers to reach to the targeting sites, and controlled release capabilities, etc. Examples of such systems include nanoemulsions, liposomes and polymer nanoparticles. Despite their great potentials, major manufacturing challenges exist such as precisely control particle size and size distribution, achieve repeatable and scalable results, comply with all cGMP requirements and product sterilizable, e.g., through terminal sterile filtration. Microfluidizer® technology is an advanced technology that satisfies all of the requirements by delivering superior uniform shear and energy dissipation rates through the utilization of fixed geometry interaction chamber and constant process pressure. The unique benefits are presented here with three case studies. The first case study compares making an oil-in-water nanoemulsion adjuvant with post-processing sterile filtration using both of the Microfluidizer and traditional high-pressure homogenization technology. Microfluidizer was able to produce nanoemulsions have much higher filterability due to smaller droplets and narrower distribution. The process also showed excellent energy efficiency. The second and third case studies demonstrate producing and scaling up of a liposomal antibiotic formulation and fabricating two different polymer particles, one solid and the other one with embedded nanoparticles, respectively. In summary, Microfluidizer® technology is very efficient, reliable, and well-suited for manufacturing drug delivery nanoparticles for the pharmaceutical industry from development to production